Virtu Financial’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25K Buy
+12,589
New +$18.2K ﹤0.01% 1318
2025
Q3
Sell
-18,166
Closed -$68K 1722
2025
Q2
$68K Buy
+18,166
New +$71.5K ﹤0.01% 1096
2025
Q1
Sell
-15,497
Closed -$110K 1633
2024
Q4
$110K Buy
+15,497
New +$123K 0.01% 1001
2020
Q3
Sell
-13,310
Closed -$388K 1256
2020
Q2
$388K Buy
+13,310
New +$368K 0.04% 455

Other funds holding HCAT

Virtu Financial's HCAT Position: Q2 2026 in Review

Virtu Financial opened a new position in Health Catalyst (HCAT) in Q2 2026: 12,589 shares worth $25K. The stake represents ﹤0.01% of the portfolio and ranks #1318 among its holdings. This is a return to the name: Virtu Financial previously reported a position in HCAT as recently as Q2 2025.

Virtu Financial first reported a position in HCAT in Q2 2020 and has held it in 4 quarters since. The position peaked at $388K in Q2 2020. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Virtu Financial held 12,589 shares of Health Catalyst worth $25K as of Q2 2026.
  • Health Catalyst was a new Virtu Financial position in Q2 2026.
  • Health Catalyst made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1318 holding.
  • Virtu Financial first reported a position in Health Catalyst in Q2 2020 and has held it in 4 quarters since.
  • Virtu Financial's Health Catalyst position peaked at $388K in Q2 2020.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.